TP53 and cancer: Strikingly, the overall differences in module activity between normal and tumour cells were less pronounced than lineage‐specific variations, suggesting that much of the p53 loss‐driven tumour heterogeneity observed in cancer cells faithfully reflects the biology of their cell of origin.